<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">HPV </span>
   <span class="font20">HIV </span>
   <span class="font19">women </span>
   <span class="font18">(.) </span>
   <span class="font14">genotypes </span>
   <span class="font14">cervical </span>
   <span class="font14">study </span>
   <span class="font14">human </span>
   <span class="font14">{border-style </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">[]. </span>
   <span class="font13">rate </span>
   <span class="font13">risk </span>
   <span class="font12">infection </span>
   <span class="font12">papillomavirus </span>
   <span class="font12">viral </span>
   <span class="font12">positivity </span>
   <span class="font12">vs. </span>
   <span class="font12">cancer </span>
   <span class="font12">HR-HPV </span>
   <span class="font12">higher </span>
   <span class="font12">status </span>
   <span class="font12">(%) </span>
   <span class="font12">Total </span>
   <span class="font12">age </span>
   <span class="font11">(.% </span>
   <span class="font11">HPV-infection </span>
   <span class="font11">Human </span>
   <span class="font11">compared </span>
   <span class="font11">population </span>
   <span class="font11">virus </span>
   <span class="font11">(/) </span>
   <span class="font11">.%, </span>
   <span class="font11">associated </span>
   <span class="font11">genotype </span>
   <span class="font11">performed </span>
   <span class="font11">prevalence </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font11">CIRCB </span>
   <span class="font11">Disponible </span>
   <span class="font11">[cité </span>
   <span class="font11">burden </span>
   <span class="font11">different </span>
   <span class="font11">font-size </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">load </span>
   <span class="font11">oncogenic </span>
   <span class="font11">sur: </span>
   <span class="font11">women, </span>
   <span class="font11">(Table </span>
   <span class="font11">According </span>
   <span class="font11">HIV-infection </span>
   <span class="font11">HIV-negative </span>
   <span class="font11">HIV-seropositive </span>
   <span class="font11">P-value </span>
   <span class="font11">Table </span>
   <span class="font11">[], </span>
   <span class="font11">according </span>
   <span class="font11">cancers </span>
   <span class="font11">double; </span>
   <span class="font11">genotyping </span>
   <span class="font11">high </span>
   <span class="font11">infected </span>
   <span class="font11">obtained </span>
   <span class="font11">sexual </span>
   <span class="font11">significantly </span>
   <span class="font11">using </span>
   <span class="font11">Commons </span>
   <span class="font11">Creative </span>
   <span class="font11">HIV- </span>
   <span class="font11">HIV-infected </span>
   <span class="font11">International </span>
   <span class="font11">RNA </span>
   <span class="font11">acquiring </span>
   <span class="font11">analysis </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">divorced </span>
   <span class="font11">evidence </span>
   <span class="font11">factor </span>
   <span class="font11">immune </span>
   <span class="font11">living </span>
   <span class="font11">median </span>
   <span class="font11">national </span>
   <span class="font11">participants </span>
   <span class="font11">p = .), </span>
   <span class="font11">screening </span>
   <span class="font11">sexually </span>
   <span class="font11">similar </span>
   <span class="font11">single </span>
   <span class="font11">solid; </span>
   <span class="font11">status, </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">Abbott </span>
   <span class="font10">Cameroon </span>
   <span class="font10">Centre </span>
   <span class="font10">Ethics </span>
   <span class="font10">HIV-positive </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Ref </span>
   <span class="font10">Yaoundé, </span>
   <span class="font10">[Internet]. </span>
   <span class="font10">anal </span>
   <span class="font10">bold </span>
   <span class="font10">clinical </span>
   <span class="font10">co-infection </span>
   <span class="font10">considered </span>
   <span class="font10">copies/ml </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">detection </span>
   <span class="font10">em; </span>
   <span class="font10">enrolled </span>
   <span class="font10">following </span>
   <span class="font10">high-risk </span>
   <span class="font10">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC/. </span>
   <span class="font10">increasing </span>
   <span class="font10">infections </span>
   <span class="font10">likely </span>
   <span class="font10">marital </span>
   <span class="font10">molecular </span>
   <span class="font10">normal </span>
   <span class="font10">papilloma </span>
   <span class="font10">papillomavirus, </span>
   <span class="font10">pt;} </span>
   <span class="font10">p = .). </span>
   <span class="font10">reported </span>
   <span class="font10">samples </span>
   <span class="font10">sept </span>
   <span class="font10">systematic </span>
   <span class="font10">times </span>
   <span class="font10">vaccine </span>
   <span class="font10">viremia </span>
  </p>
 </body>
</html>
